LysoPC(20:3/0:0)
|
Basic information |
| Metabolite name | LysoPC(20:3/0:0) |
 | HMDB0010393 |
 |
C04230 |
 |
53480467 |
| Synonyms | LysoPC(20:3(5Z,8Z,11Z)) |
| No. of studies | 5 |
|
Basic information |
| Metabolite name | LysoPC(20:3/0:0) |
| HMDB0010393 |
|
C04230 |
|
53480467 |
| Synonyms | LysoPC(20:3(5Z,8Z,11Z)) |
| No. of studies | 5 |
|
Relationship between LysoPC(20:3/0:0) and depression (count: 5) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M460 | Type1 | depressed group vs. control group | Liver | Kunming mouse | Down |
| Study M469 | Type1 | Parkinson's disease with depression group vs. Parkinson's disease without depression group | Plasma | Human | Down |
| Study M572 | Type1 | major antenatal depression group vs. control group | Plasma | Human | Up |
| Study M743 | Type1 | CUS group vs. control group | Plasma | Sprague-Dawley rat | Down |
| Study M918 | Type1 | methamphetamine group vs. control group | Serum | C57BL/6 mouse | Down |